173 related articles for article (PubMed ID: 31139014)
1. Low expression of SPARC in gastric cancer-associated fibroblasts leads to stemness transformation and 5-fluorouracil resistance in gastric cancer.
Ma Y; Zhu J; Chen S; Ma J; Zhang X; Huang S; Hu J; Yue T; Zhang J; Wang P; Wang X; Rong L; Guo H; Chen G; Liu Y
Cancer Cell Int; 2019; 19():137. PubMed ID: 31139014
[TBL] [Abstract][Full Text] [Related]
2. Astragaloside IV inhibits pathological functions of gastric cancer-associated fibroblasts.
Wang ZF; Ma DG; Zhu Z; Mu YP; Yang YY; Feng L; Yang H; Liang JQ; Liu YY; Liu L; Lu HW
World J Gastroenterol; 2017 Dec; 23(48):8512-8525. PubMed ID: 29358859
[TBL] [Abstract][Full Text] [Related]
3. Paeoniflorin Inhibits Migration- and Invasion-Promoting Capacities of Gastric Cancer Associated Fibroblasts.
Wang ZF; Ma DG; Wang L; Feng L; Fu JW; Li Y; Wang DT; Jia YF
Chin J Integr Med; 2019 Nov; 25(11):837-844. PubMed ID: 30361813
[TBL] [Abstract][Full Text] [Related]
4. Gallbladder cancer-associated fibroblasts promote vasculogenic mimicry formation and tumor growth in gallbladder cancer via upregulating the expression of NOX4, a poor prognosis factor, through IL-6-JAK-STAT3 signal pathway.
Pan MS; Wang H; Ansari KH; Li XP; Sun W; Fan YZ
J Exp Clin Cancer Res; 2020 Nov; 39(1):234. PubMed ID: 33153467
[TBL] [Abstract][Full Text] [Related]
5. Triptonide inhibits the pathological functions of gastric cancer-associated fibroblasts.
Wang Z; Ma D; Wang C; Zhu Z; Yang Y; Zeng F; Yuan J; Liu X; Gao Y; Chen Y; Jia Y
Biomed Pharmacother; 2017 Dec; 96():757-767. PubMed ID: 29049979
[TBL] [Abstract][Full Text] [Related]
6. Upregulated NOX1 expression in gallbladder cancer‑associated fibroblasts predicts a poor prognosis.
Wang FT; Hassan M; Ansari KH; Xu GL; Li XP; Fan YZ
Oncol Rep; 2019 Oct; 42(4):1475-1486. PubMed ID: 31364740
[TBL] [Abstract][Full Text] [Related]
7. Activated gastric cancer-associated fibroblasts contribute to the malignant phenotype and 5-FU resistance via paracrine action in gastric cancer.
Ma Y; Zhu J; Chen S; Li T; Ma J; Guo S; Hu J; Yue T; Zhang J; Wang P; Wang X; Chen G; Liu Y
Cancer Cell Int; 2018; 18():104. PubMed ID: 30038550
[TBL] [Abstract][Full Text] [Related]
8. SPARC enhances 5-FU chemosensitivity in gastric cancer by modulating epithelial-mesenchymal transition and apoptosis.
Ma J; Ma Y; Chen S; Guo S; Hu J; Yue T; Zhang J; Zhu J; Wang P; Chen G; Liu Y
Biochem Biophys Res Commun; 2021 Jun; 558():134-140. PubMed ID: 33910127
[TBL] [Abstract][Full Text] [Related]
9. The relationship between stromal cell derived SPARC in human gastric cancer tissue and its clinicopathologic significance.
Gao Y; Yin SP; Xie XS; Xu DD; Du WD
Oncotarget; 2017 Oct; 8(49):86240-86252. PubMed ID: 29156791
[TBL] [Abstract][Full Text] [Related]
10. Caveolin-1 is a modulator of fibroblast activation and a potential biomarker for gastric cancer.
Shen XJ; Zhang H; Tang GS; Wang XD; Zheng R; Wang Y; Zhu Y; Xue XC; Bi JW
Int J Biol Sci; 2015; 11(4):370-9. PubMed ID: 25798057
[TBL] [Abstract][Full Text] [Related]
11. Identification of the prognostic value of elevated ANGPTL4 expression in gallbladder cancer-associated fibroblasts.
Wang FT; Li XP; Pan MS; Hassan M; Sun W; Fan YZ
Cancer Med; 2021 Sep; 10(17):6035-6047. PubMed ID: 34331381
[TBL] [Abstract][Full Text] [Related]
12. NANOGP8 is the key regulator of stemness, EMT, Wnt pathway, chemoresistance, and other malignant phenotypes in gastric cancer cells.
Ma X; Wang B; Wang X; Luo Y; Fan W
PLoS One; 2018; 13(4):e0192436. PubMed ID: 29689047
[TBL] [Abstract][Full Text] [Related]
13. Extract of
Cui XL; Li KJ; Ren HX; Zhang YJ; Liu XD; Bu BG; Wang L
World J Gastroenterol; 2019 Apr; 25(15):1854-1864. PubMed ID: 31057299
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of SPARC gene in human gastric carcinoma and its clinic-pathologic significance.
Wang CS; Lin KH; Chen SL; Chan YF; Hsueh S
Br J Cancer; 2004 Nov; 91(11):1924-30. PubMed ID: 15558074
[TBL] [Abstract][Full Text] [Related]
15. E2F1 Maintains Gastric Cancer Stemness Properties by Regulating Stemness-Associated Genes.
Fu Y; Hu C; Du P; Huang G
J Oncol; 2021; 2021():6611327. PubMed ID: 33986804
[TBL] [Abstract][Full Text] [Related]
16. Macrophage-derived SPARC Attenuates M2-mediated Pro-tumour Phenotypes.
Hu J; Ma Y; Ma J; Chen S; Zhang X; Guo S; Huang Z; Yue T; Yang Y; Ning Y; Zhu J; Wang P; Wang X; Chen G; Liu Y
J Cancer; 2020; 11(10):2981-2992. PubMed ID: 32226513
[TBL] [Abstract][Full Text] [Related]
17. SPARC mediates metastatic cooperation between CSC and non-CSC prostate cancer cell subpopulations.
Mateo F; Meca-Cortés O; Celià-Terrassa T; Fernández Y; Abasolo I; Sánchez-Cid L; Bermudo R; Sagasta A; Rodríguez-Carunchio L; Pons M; Cánovas V; Marín-Aguilera M; Mengual L; Alcaraz A; Schwartz S; Mellado B; Aguilera KY; Brekken R; Fernández PL; Paciucci R; Thomson TM
Mol Cancer; 2014 Oct; 13():237. PubMed ID: 25331979
[TBL] [Abstract][Full Text] [Related]
18. High secreted protein acidic and rich in cysteine expression in peritumoral fibroblasts predicts better prognosis in patients with resectable gastric cancer.
Nakajima M; Yoshino S; Kanekiyo S; Maeda N; Sakamoto K; Tsunedomi R; Suzuki N; Takeda S; Yamamoto S; Hazama S; Hoshii Y; Oga A; Itoh H; Ueno T; Nagano H
Oncol Lett; 2018 Jan; 15(1):803-812. PubMed ID: 29403557
[TBL] [Abstract][Full Text] [Related]
19. LY294002 may overcome 5-FU resistance via down-regulation of activated p-AKT in Epstein-Barr virus-positive gastric cancer cells.
Shin JY; Kim JO; Lee SK; Chae HS; Kang JH
BMC Cancer; 2010 Aug; 10():425. PubMed ID: 20704765
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial and ribosomal biogenesis are new hallmarks of stemness, oncometabolism and biomass accumulation in cancer: Mito-stemness and ribo-stemness features.
Peiris-Pagès M; Ozsvári B; Sotgia F; Lisanti MP
Aging (Albany NY); 2019 Jul; 11(14):4801-4835. PubMed ID: 31311889
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
